Viewing Study NCT05637268


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2025-12-29 @ 3:55 AM
Study NCT ID: NCT05637268
Status: UNKNOWN
Last Update Posted: 2022-12-05
First Post: 2022-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module